Get started
Author

Kai Soon Ng

Observed name: NG KAI SOON
ORCID: 0009-0004-8575-4166
Observed ORCID: 0009-0004-8575-4166
OpenAlex ID: A5076857125
Paxillin interactome identified by SILAC and label-free approaches coupled to TurboID sheds light on the compositions of focal adhesions in mouse embryonic stem cells
2023 · Qianqian He, Siu Kwan Sze, et al. · Biochemical and Biophysical Research Communications · 5
PDF
A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL
2026 · Michaela Su-fern Seng, Zexi Guo, et al. · Blood Cancer Discovery · 1
PDF
1311 H&E 2.0: deep learning-enabled identification of tumor-specific CD39+CD8+ T cells in marker-free images for predicting immunotherapy response
2023 · Felicia Wee, Willa Yim, et al. · Journal for ImmunoTherapy of Cancer · 1
Cancer Immunotherapy
2026 · DENISE GOH, NG KAI SOON, et al. · Wiley eBooks
Multiomic signatures of durable response in a Phase I/II trial of tandem aCD22-aCD19 CAR-T therapy for relapsed B-lineage acute lymphoblastic leukaemia
2025 · Michaela Su-Fern Seng, Shui Yen Soh, et al. · Blood
PDF
Abstract 5913: Longitudinal blood-based immuno-monitoring reveals distinct immune profiles in colorectal cancer patients with divergent responses to first-line systemic therapy
2025 · Jia Meng, Yong Xiang Gwee, et al. · Cancer Research
Abstract 2549: The aged tumor microenvironment limits T cell control of breast cancer
2025 · Jia Meng, Denise Goh, et al. · Cancer Research
431 LongiBloodImmunoM: longitudinal blood-based immunomonitoring of CAR-T cell therapy patients for predictive biomarkers
2023 · Jia Meng, Kai Soon Ng, et al. · Journal for ImmunoTherapy of Cancer
PDF
Works count: 8
Citation count: 7
H-index: 1
I10-index:
Year
Topic
Type